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A major challenge in the application of mesenchymal stem cells in cartilage reconstruction is that whether the cells are able to
differentiate into fully mature chondrocytes before grafting. The aim of this study was to isolate mouse dental pulp stem cells
(DPSC) and differentiate them into chondrocytes. For this investigation, morphological, molecular, and biochemical analyses for
differentiated cells were used. To induce the chondrocyte differentiation, DPSC were cultured in chondrogenic medium (Zen-
Bio, Inc.). Based on morphological analyses using toluidine blue staining, proteoglycan products appear in DPSC after 21 days of
chondrocyte induction. Biochemical analyses in differentiated group showed that alkaline phosphatase activity was significantly
increased at day 14 as compared to control (P < 0.05). Cell viability analyses during the differentiation to chondrocytes also
showed that these cells were viable during differentiation. However, after the 14th day of differentiation, there was a significant
decrease (P < 0.05) in the viability proportion among differentiated cells as compared to the control cells. In RT-PCR molecular
analyses, mouse DPSC expressed Cd146 and Cd166 which indicated that these cells belong to mesenchymal stem cells. Coll I and
Coll II markers showed high expression after 14 and 21 days, respectively. In conclusion, this study showed that DPSC successfully
differentiated into chondrocytes.
1. Introduction
In recent years, new cellular therapy methods have opened a
clear horizon for treatment of various injuries and diseases.
Globally, many people experience at least one form of
cartilage tissue injuries. These injuries are usually the result
of traumas or tissue degeneration due to age related diseases.
Since there is lack of vascular system in cartilage tissue or
an active supply system for cartilage tissues that covering at
the ends of bones, growth factors that exist in blood that is
needed for cellular healing are thus limited. This results in a
restricted ability of self-healing in these tissues [1].
The demand for chondrocyte grafting has increased in
recent years, but there are limitations as it cannot be used
for vast cartilage injuries. Access to other cellular resources
for the production of cartilage tissues and grafting is thus
crucial in the treatment of cartilage injuries [2]. Stem cells
can be an alternative resource for the purpose of cartilage
injury healing. The main focus for regenerative research
is to explore the potential resource for cellular therapy.
Mesenchymal stem cells can be found in the bone marrow
[3], muscle tissues [4], cartilages [5], tendons [6], umbilical
cord [7], and umbilical cord blood [8]. Among stem cells
with mesenchymal origin, those from the bone marrow have
received more attention [9]. A bone marrow stromal cell is
a type of mesenchymal stem cell found in the bone marrow.
They are able to give rise to bones and cartilages [10]. One
point that should be noted in the definition of these cells
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is that their attachment to the bottom of culture dishes
could be used as a way of recognizing them [11]. Cells
which attach to the bottom of culture dishes are heterogenic,
consisting of progenitor and stem cells [12] and their
fate changes depending on the differentiation environment.
For example, ascorbic acid, nonorganic phosphates and
dexamethasone can influence the differentiation of these cells
into osteoblasts [13], while transforming growth factor B can
impose chondrogenic markers in these cells [14].
Teeth are rich, unique and accessible sources of mes-
enchymal stem cells that are suitable for applied research
and tissue engineering applications [15]. Following ectomes-
enchymal interactions (confrontation) occurring between
the dental ridges and its underlying mesenchyme, dental
layers are formed. Dental layers are further differentiated
into dental organs; dental papilla and dental follicles. Finally,
major dental structures and periodontal tissues are devel-
oped. Meanwhile, dental pulp is formed from mesenchymal
neural crests with multipotent abilities [16]. The purpose of
this study was to investigate the chondrogenic capacity of
mouse dental pulp cells and identify DPSC differentiation
into chondrocytes through morphological, molecular, and
biochemical analyses.
2. Materials and Methods
2.1. Isolation of DPSC. In this experimental study, teeth
were obtained from mouse aged 6–8 weeks. Surfaces of
teeth were cleaned with phosphate-buffered saline (PBS) and
kept in sterile PBS solution containing 1% (v/v) penicillin-
streptomycin at 4◦C. The teeth were then extracted from jaw
using a sterile scalpel, while dental pulps were removed from
teeth using sterile forceps. After this, the crown and root were
cut with surgical scissors. The dental pulp was washed with
PBS containing 1% (v/v) penicillin-streptomycin and was
placed in 4 U of collagenase type 1 at 37◦C. Single cells from
dental tissues were obtained by pipetting the cells several
times in α-modified Eagle’s medium (AMEM). After this, the
cells were centrifuged at 1200 g for 10 minutes. The pellet was
resuspended with complete medium (AMEM supplemented
with 20% v/v fetal bovine serum) and cultured in a 6-well
plate. For cultivation, cells were transferred into T25 flasks
containing complete medium and kept in incubator with a
temperature of 37◦C and humidity of 95% and 5% CO2.
2.2. Differentiation to Chondrocyte Cells. Approximately 1 ×
105 cells/mL were transferred to 24-well plates and kept in
incubator with a temperature of 37◦C and humidity of 95%
and 5% CO2. After washing the cells with 1 X PBS, the
cells were placed in chondrogenic medium (Zen-Bio, Inc.)
for 21 days to observe for chondrocyte differentiation. Spent
medium was replaced with fresh complete medium after
every 3 days.
2.3. Chondrocyte Cell Staining. After 21 days of culturing
in chondrogenic medium, the cells were first fixed in
formaldehyde 4% (v/v) for 2 hours. Then, they were treated
sequentially with alcohol 75% (v/v), 95% (v/v), and 100%
(v/v). Finally, the cells were stained by toluidine blue for 2
minutes at room temperature.
2.4. RNA Isolation for Chondrocyte Cells. Total RNA was
extracted from these cells using Trizol at day 1, 14 and 21.
The cells were detached from the T25 flask using 0.25%
(v/v) trypsin/EDTA. Cells were then centrifuged at 1200 g
for 10 minutes, and the obtained pellet was lysed with 1 mL
TRIZOL (Regent-Total RNA Isolation Regent) (Invitrogen,
USA) for 5 minutes at room temperature. Approximately
0.2 mL chloroform (SYSTERM) was added into the sample
and vortexed for 15 seconds. This was followed by centrifuga-
tion at 12000 g for 15 minutes at 4◦C. The colorless aqueous
phase was taken as the RNA. This phase was transferred into
new tube, and 0.5 mL of 100% (v/v) isopropanol was added
and incubated at room temperature for 10 minutes. After
that, the sample was centrifuged at 12000 g for 10 minutes at
4◦C. The supernatant was discarded, and the RNA pellet was
washed with 15% (v/v) ethanol. The sample was centrifuged
again at 7500 g for 5 minutes at 4◦C. The supernatant was
discarded, and the RNA pellet dried at room temperature for
5 minutes before resuspending in 25 mL free nuclease water
and incubated at 55◦C for 15 minutes. The obtained RNA
was stored at -80◦C until use.
2.5. Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR). Materials for RT-PCR ( Access Quick RT-PCR Kit
System, Promega) were 5X reaction buffer AMV/Tfi, dNTP
mix (10 mM), forward and reverse primers (50 pmol),
MgSO4 (25 mM), reverse transcriptase (5 U/μL), template
RNA (0.5 μg), and nuclease free water. Briefly, RT-PCR
reaction was conducted using chondrocyte cells primers,
that is, including Coll I and Coll II (Table 1). RT-PCR
program was conducted with thermocycler conditions as
follows: primary cDNA synthesis at 45◦C for 45 minutes
and deactivation of the AMV reverse transcriptase at 94◦C
for 2 minutes. Secondary cDNA synthesis, including 40
cycles of denaturation, at 94◦C for 30 seconds, with 1
minute annealing using primer-specific temperature and 2
minutes of primary extension at 68◦C were conducted. Final
extensions at 68◦C for 7 minutes were performed. Two
percent agarose gel (Vivantis Inc. USA) and 1X buffer TAE
was used for gel electrophoresis. After electrophoresis, gel
was stained with EtBr and observed under UV light.
2.6. Alkaline Phosphatase Activity. Alkaline phosphatase
(ALP) activity was assayed enzymologically. The DPSC was
seeded at a density of 1 × 103 cells/mL in 96-well plates. At
day 1, 5, 7, 10, 14, and 21 of culture with differentiation
medium and control medium, the ALP activity of DPSC
was determined using an ALP assay. Spent control and
differentiation mediums were replaced with fresh medium
after every two days. After washing with 1X PBS, the cells
were incubated in 0.1 M NaNO3-Na2CO3 buffer (pH 10.0)
(w/v) (R&M, U.K) containing 1% ( v/v) Triton X100 (Sigma,
USA) and 2 mM MgSO4 (w/v) (Sigma, USA). Subsequently,
6 mM P-Nitrophenyl Phosphate (w/v) (Sigma, USA) was
added as substrate to each 96-well and incubated for 30
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Table 1: Primes and the reaction conditions of RT-PCR.
Name Sense primer Antisense primer Accession No. Prod. length (bp) Ann. T (◦C)
CD 146 5′GGACCTTGAGTTTGAGTGG3′ 5′CAGTGGTTTGGCTGGAGT3′ NM 023061 479 60
CD 166 5′AACATGGCGGCTTCAACG3′ 5′GACGACACCAGCAACGAG3′ NM 009655 630 61
CD31 5′GGTCTT GTCGCAGTATCAG3′ 5′ATGGCAATTATCCGCTCT3′ NM 001032378.1 355 58
Gapdh 5′CAACGGCACAGTCAAGG3′ 5′AAGGTGGAAGAGTGGGAG3′ NM 008084 717 62
Coll II 5′TGGTGGAGCAGCAAGAG3′ 5′ATGGGTGCGATGTCAAT3′ NM 001113515 398 53









Figure 1: Characteristics of isolated and in vitro mouse DPSC colony formation after cultured DPSC at the first passage (a and b). Cell after
48 hours after culture (c) and fibroblastic-like cells shape (d).
minute at 37◦C. Finally, 1.5 M NaOH (sodium hydroxide)
(w/v) (Labguard, USA) was added to stop the enzyme
substrate reaction. Optical density (OD) readings were taken
at wavelength of 405 nm using a spectrophotometer.
2.7. MTT Assay for Chondrocyte Cells. Approximately 1×103
cells/mL was placed in 96-well dishes after incubation at
37◦C for 24 hours. The cells were washed with 1X PBS
and divided into two groups, that is, control and chondro-
cyte induction. Following this, the cells were cultured in
the chondrocyte medium (induction group) and complete
medium (control group) for 1, 3, 5, 7, 10, 12, 14, 16, 18,
and 21 days. The sample design included three replicates for
each treatment and five absorbance measurements for each
sample. Twenty microlitre of MTT (5 mg/mL in phosphate
buffered saline, PBS) were added to each well and the samples
incubated at 37◦C for 4 hours. After removing the mixture,
the insoluble purple-blue formazan crystals were dissolved
with 200 μL DMSO (dimethyl sulfoxide). The cells were
then incubated for 15 minutes at room temperature. The
absorbance was thereafter measured at 570 nm using an
ELISA reader.
2.8. Statistical Analysis. Statistical comparison between the
chondrocyte differentiated groups and control were carried
out using t-test. Observed differences were considered statis-
tically significant when P < 0.05.
3. Results
In this study, after dental pulp tissues were digested with
collagenase enzyme, spherical cells appeared. After 24 hours,
cells which were placed in culture plate changed into fibrob-
lastic shape with stretched form and circular nucleus. The









Figure 2: Characteristics of chondrocyte derived from mouse DPSC. After chondrogenic induction, the cytoplasm contracted toward the
nucleus and formed spherical cells without branch (a and b). Glycosaminoglycans in chondrocyte tissue were stained by toluidine blue and
showed blue in colors (c). Control groups without chondrogenic induction (d).
morphology of mouse dental pulp cells and chondrogenic
ability of these cells is illustrated in Figures 1(a) and 1(b).
To differentiate DPSC to chondrocytes, only the fourth cell
passage was used. After 21 days of culture in chondrogenic
induction medium, the cellular morphological characters
had changed.
After chondrogenic induction, the cytoplasm contracted
toward the nucleus and formed round shape cells without
branches (Figures 2(a) and 2(b)). Cells that have been
cultured in chondrocyte differentiation medium were stained
by toluidine blue to produce blue colors (Figure 2(c)).
Toluidine blue staining revealed an increased production
of glycosaminoglycan during induction, a phenomenon
noticed only among chondrocyte cells.
In RT-PCR, mouse DPSC where showed to express
Cd146 and Cd166 indicating that these cells belong to
mesenchymal stem cells (Figures 3(a) and 3(b)). Since these
cells did not express Cd31 (Figure 3(c)), it showed that they
do not belong to hematopoietic stem cells. On the other
hand, Coll I marker was shown to be highly expressed after
14 days of induction (Figure 3(e), L1) as compared to before
induction (Figure 3(e), L2) whereas activation of Coll II as
mature chondrocyte cells markers was observed after 21 days
treatment with chondrocyte induction medium (Figure 3(f),
L1). On the other hand, before induction (Figure 3(f), L2)
showed no amplification of Coll II.
Cell viability analyses using MTT assay during dif-
ferentiation stage showed that the proliferation ability of
differentiated cells is weaker as compared to the control.
Statistical analyses also demonstrated significant differences
(P < 0.05) between the control and chondrogenic induction
group at day 7 until 21 (Figure 4). ALP activity of DPSC
cultured in chondrogenic differential medium was detected
using an ALP enzymological assay. After 14 days of culturing
DPSC in the chondrogenic induced medium, results showed
that most of the cells became alkaline phosphatase positive
as compared to control cells which were cultured in AMEM
and 15% (v/v) FBS. Enzymatic activity of differentiated cells
reached the highest value after 21 days (Figure 5).
4. Discussions
Expression of STRO 1 and CD146 as human markers
are amongst DPSC characteristics. These two markers are
expressed at the peripheral vascular and neural areas in
dental pulp [17]. In our study, Cd146 and Cd166 markers
were also shown to be expressed in the basal culture medium.
Furthermore, Laino et al. [18] demonstrated that DPSC
frozen for 2 years manifested not only the characteristics of
fresh DPSC but also maintained the ability to differentiate
into bone cells when cultured in appropriate medium [18,
19].
Despite the physical strength of cartilages, these cells
are capable of self-repair after significant trauma or disease.
Regenerative cartilages are thus important candidates for
regenerative medicine [20]. Production of these cells is
























Figure 3: RT-PCR analyses of mouse DPSC in 1% (w/v) Agarose. (a) Cd146 (479 bp), (b) Cd166 (630 bp), (c) Cd 31(355 bp), (d) Gapdh as
a house keeping gene (717 bp). (e, L1) The Coll I marker (532 bp) was after 14 days induction and (e, L2) before induction. (f, L1) Coll II
after 21 days induction and (f, L2) before induction.
essential since cartilages have low cellular density. On the
other hand, high numbers of cells are usually needed for
cellular therapy [21]. Currently, various treatment methods
are being used to reconstruct cartilages. One of the treatment
approaches is cellular therapy using autologous chondrocytes
[21]. Since chondrocytes show morphological changes and
lose differentiation capability during in vitro culture, it is
essential to find alternative cells that could retain this ability
[22, 23].
Imabayashi et al. [24] showed that differentiated chon-
drocytes need three-dimensional culture to acquire differ-
entiation characteristic. Application of mesenchymal cells in
cartilage reconstruction was applied because it was believed
that mesenchymal cells could differentiate into complete
mature chondrocytes before grafting [24]. This approach
guarantees chondrocytes transition to the targeted location
and prevented unexpected differentiation in joint cartilage
injury [25]. Hence, in this study we used in vitro methods
to investigate the potency of DPSC to differentiate into
chondrocytes.
There are limitations in differentiation of mesenchymal
stem cell into chondrocytes. However, growth factors like
TGF and the absence of serum can be used in bone marrow
mesenchymal stem cells to overcome these limitations [26].
Zuk et al. [27] used growth factor TGF-β1 during chon-
drocyte differentiation of mesenchymal stem cells originated
from human adipose tissues. Sekiya et al. [28] reported that
production of proteoglycans increased in stem cells derived
from bone marrow by adding BMP-6 into culture medium.
On the other hand, some studies revealed that ascorbic acid

























Figure 4: Cell viability by using MTT assay. The results were
presented as mean ± SD. Statistical analysis was conducted by t-
test. Comparison of data between controls and groups showed


































Figure 5: Alkaline Phosphatase (ALP) assay. Statistical analysis
using paired t-test. Comparison of data between controls and
differentiated groups showed significant difference (∗) after 14 days
and 21 days (P < 0.05; n = 3).
could stimulate in vitro differentiation and proliferation of
various mesenchyme-derived cell types such as osteoblasts
[29–31], adipocyte [32], and chondrocytes [33, 34].
The most appropriate factors needed to differentiate
stem cells into chondrocytes have not been identified yet.
However, the groups of TGF growth factors are important
among chondrogenic inducing factors. These factors play a
key role in regulation of cellular growth, cellular differenti-
ation, cartilage, and bone development [35]. Some studies
have shown that TGF isoforms are not merely enough for
mesenchymal stem cell differentiation, and that additional
factors such as BMP are needed to induce increment of
proteoglycans [28]. DPSC under the influence of TGF with
high cellular intensity that is present in Zen Bio medium were
therefore used in this study as chondrogenic differentiation
inducer.
As indicated by other studies, existence of Coll II and
proteoglycan are indicators of cartilage tissue [27, 36]. In this
study, determination of Coll II chondrocyte markers after
differentiation revealed that these markers were expressed
after 21 days in differentiated medium (Figure 3(f), L1).
While Coll I was observable before differentiation, it
increased its expression after 14 days (Figure 3(e), L1 and
3(e), L2). Investigation of alkaline phosphatase activity was
a proof for this claim as statistical analysis showed significant
differences (P < 0.05) in differentiation among cells treated
by chondrogenic medium as compared to control on the 14th
and 21st day (Figure 5).
Cell viability during differentiation into chondrocytes
(Figure 4) also showed that cells preserved their viability
during differentiation, but after the 14th day of culture the
cell viability ratio between differentiated and control cells
was significantly decreased (P < 0.05). This shows that these
cells lose their ability to proliferate during the differentiation
process.
In conclusion, this study indicated that DPSC with high
proliferation rate had chondrogenic differentiation capacity.
This type of stem cells might be suitable for autologous
chondrocyte repair.
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